Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Opdivo and Keytruda are potential alternatives to current first-line therapies.
Any amount of alcohol can increase a person’s risk for several types of cancer, including cancers of the throat, esophagus, and liver.
Delays in screening, diagnosis and treatment could lead to poorer outcomes.
Checkpoint inhibitor extended survival by about three months compared with chemotherapy.
April is Esophageal Cancer Awareness Month.
Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.
A consortium of health providers and researchers hopes to raise public awareness of how exercise can benefit those living with cancer.
pembrolizumab’s efficacy was investigated in two clinical trials of people with recurrent, locally advanced or metastatic disease.
A low dose of platinum-based chemotherapy worked as well as higher doses for elderly and frail people with esophageal and stomach cancer.
Cancer cause and cure headlines can often be confusing or misleading.
A third of patients taking neoadjuvant Opdivo for inoperable advanced liver cancer had complete responses in an early analysis.
Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.
Keytruda improved survival in people with favorable tumor biomarkers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.